WINDTREE THERAPEUTICS INC /DE/ Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of -$76.00 thousand for the 24-month period ending 2017-12-31, per its 10-K filed 2018-04-17.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2018-04-17
- WINDTREE THERAPEUTICS INC /DE/ effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2016 was $76.00, a 73.70% decline from fiscal 2015.
- WINDTREE THERAPEUTICS INC /DE/ effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2015 was $289.00.
- WINDTREE THERAPEUTICS INC /DE/ effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2014 was -$1.29M.
- WINDTREE THERAPEUTICS INC /DE/ effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2013 was -$259.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month as first filed | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 24 month |
|---|---|---|---|
| 2017-12-31 | -$76.00K 10-K · filed 2018-04-17 | ||
| 2016-12-31 | $76.00 10-K · filed 2017-03-31 | ||
| 2015-12-31 | $289.00 10-K · filed 2017-03-31 | -$289.00K 10-K · filed 2016-03-29 | |
| 2014-12-31 | -$1.29M 10-K · filed 2016-03-29 | ||
| 2013-12-31 | -$259.00K 10-K · filed 2015-03-16 | ||
| 2012-12-31 | -$189.00K 10-K · filed 2015-03-16 | ||
| 2011-12-31 | -$1.21M 10-K · filed 2014-03-17 | ||
| 2010-12-31 | -$2.18M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |